65037-18-5 Usage
Description
Benzenebutanoic acid, 2-bromo-alpha, gamma-dioxo-, ethyl ester is an organic chemical compound with the molecular formula C12H11BrO4. It features a benzene ring and is classified as an ester, which means it is derived from an alcohol and an organic acid. Benzenebutanoic acid, 2-broMo-.alpha.,.gaMMa.-dioxo-, ethyl este is used in the production of pharmaceuticals, agrochemicals, and other specialty chemicals, and serves as an intermediate in the synthesis of various compounds. It has potential applications in the pharmaceutical industry and should be handled with care due to its hazardous nature.
Uses
Used in Pharmaceutical Industry:
Benzenebutanoic acid, 2-bromo-alpha, gamma-dioxo-, ethyl ester is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs and medications.
Used in Agrochemical Production:
This chemical compound is also utilized in the production of agrochemicals, which are chemicals specifically designed to enhance crop protection and increase agricultural productivity.
Used in Specialty Chemicals:
Benzenebutanoic acid, 2-bromo-alpha, gamma-dioxo-, ethyl ester finds application in the creation of specialty chemicals, which are tailored for specific industries and purposes, such as in the development of new materials or processes.
Check Digit Verification of cas no
The CAS Registry Mumber 65037-18-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,0,3 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 65037-18:
(7*6)+(6*5)+(5*0)+(4*3)+(3*7)+(2*1)+(1*8)=115
115 % 10 = 5
So 65037-18-5 is a valid CAS Registry Number.
65037-18-5Relevant articles and documents
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors
Dou, Xiaodong,Huang, Huixia,Jiang, Lan,Jiao, Ning,Jin, Hongwei,Liu, Zhenming,Zhang, Liangren,Zhang, Lihe,Zhu, Guiwang
, (2020)
The c-Jun N-terminal kinase 3 (JNK3) plays key roles in a wide range of diseases, including neurodegeneration diseases, inflammation diseases, cancers, cardiovascular diseases, and metabolic disorders. Previously, we have identified a lead compound, (Z)-3
